Metraipolis › archive › dc_45cd02b0f357

Response Assessment of Generic Tyrosine Kinase Inhibitors in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: A Prospective Study from a Tertiary… — Europe PMC PMID:41523565

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41523565
DOI
10.7759/cureus.98893
License (as archived)
solo-consultazione
Archived
2026-11-07T17:49:35.215Z
SHA-256 of the archived text
ac7c1b9d2c52fd42f79270f9258a957c0678b2cacf40a7ca09146f249d654930
Stable URL of this page
https://metraipolis.com/documento/dc_45cd02b0f357

How to cite

Response Assessment of Generic Tyrosine Kinase Inhibitors in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: A Prospective Study from a Tertiary… — Europe PMC PMID:41523565 — Europe PMC (en), https://europepmc.org/article/MED/41523565 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_45cd02b0f357 (Metraipolis archive dc_45cd02b0f357, sha256 ac7c1b9d2c52fd42f79270f9258a957c0678b2cacf40a7ca09146f249d654930)
BibTeX
@misc{dc45cd02b0f357,
  title = {Response Assessment of Generic Tyrosine Kinase Inhibitors in Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: A Prospective Study from a Tertiary… — Europe PMC PMID:41523565},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41523565},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_45cd02b0f357; sha256 ac7c1b9d2c52fd42f79270f9258a957c0678b2cacf40a7ca09146f249d654930},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41523565. Agents can read the archived copy with the MCP tool read_document.